BSE filing, NSE: ADORMUL. Summary written from the filing by ALFA Finder's alert engine.
Thrive Future Habitats Ltd: key numbers
- Share price
- ₹82.00
- Market cap
- ₹38.32 Cr
- Revenue (annual)
- ₹1.23 Cr
- Net profit (annual)
- ₹-1.00 Cr
- P/E (TTM)
- -22.9×Sector 40.7×
- Promoter holding
- 61.24%+0.01% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Thrive Future Habitats Ltd
All →Thrive Future Habitats Board Meeting Date
Thrive Future Habitats Limited has scheduled a board meeting on November 9, 2026. The board will consider and approve un-audited standalone and consolidated financial results.
Thrive Future Habitats Convertible Warrants
Goonmeet Singh Chauhan, a non-promoter, acquired 23,46,901 Thrive Future Habitats shares by converting warrants, taking the stake to 11.38%. The filing is a SAST Regulation 29(1) disclosure.
Thrive Future Habitats Convertible Warrants
Thrive Future Habitats allotted 93,12,364 equity shares on conversion of warrants, raising ₹29.25 Crore. Paid-up capital rises to ₹20.63 Crore.
- Value
- ₹29.25 Cr
Thrive Future Habitats Other Announcement
Thrive Future Habitats Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as mandated by SEBI Regulation 31(1)(b).
Thrive Future Habitats Other Announcement
Thrive Future Habitats Limited has appointed J.C. Bhalla and Co. as Statutory Auditor and Neeta A & Associates as Secretarial Auditor for the company.
Thrive Future Habitats Annual General Meeting
Thrive Future Habitats Limited held its 78th Annual General Meeting on September 16, 2026. The meeting discussed financial adoption, auditor appointments, and borrowing limit revisions.
Other other announcement announcements
All →Capricorn Systems Global Solutions Other Announcement
Capricorn Systems reports rights issue proceeds fully utilised as of September 30, 2026, with no deviation. This is a routine Regulation 32 utilisation statement.
Shelter Pharma Other Announcement
Shelter Pharma reports no deviation in use of Rs 2602.50 lakh warrant proceeds. The statement is certified by Alvi & Associates.
Thyrocare Technologies Other Announcement
Designated person Rahul Guha bought 2,121 Thyrocare shares via market purchase on November 6, 2026, worth ₹0.10 Crore. Post-trade holding is 200,859 shares.
- Value
- ₹0.10 Cr
Aavas Financiers Other Announcement
AAVAS Financiers disclosed that Morningstar Sustainalytics improved its ESG risk score to 21.4 from 23.9. The rating was assigned voluntarily without company engagement.
Brijlaxmi Leasing & Finance Other Announcement
Brijlaxmi Leasing claims exemption from related party transaction disclosure under Regulation 23(9) for FY2025-26. Its capital and net worth fall within Regulation 15(2) limits.
Indrayani Biotech Other Announcement
Indrayani Biotech filed its quarterly shareholding pattern for 30 September 2026. Promoter group holds 32.89% of equity; this is routine compliance with no corporate event.